Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes
| Autor: | Chelsy L. Cliff, Bethany M. Williams, Christos E. Chadjichristos, Ulrik Mouritzen, Paul E. Squires, Claire E. Hills |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
hemichannels
complications QH301-705.5 adenosine triphosphate Review Eye Kidney Catalysis connexin 43 Diabetes Complications Inorganic Chemistry Animals Humans purinergic Physical and Theoretical Chemistry Biology (General) Molecular Biology QD1-999 Spectroscopy Inflammation hemichannel blockers diabetes diabetic nephropathy Organic Chemistry General Medicine Computer Science Applications diabetic retinopathy Chemistry Microvessels |
| Zdroj: | International Journal of Molecular Sciences, Vol 23, Iss 600, p 600 (2022) International Journal of Molecular Sciences |
| ISSN: | 1661-6596 1422-0067 |
| Popis: | Of increasing prevalence, diabetes is characterised by elevated blood glucose and chronic inflammation that precedes the onset of multiple secondary complications, including those of the kidney and the eye. As the leading cause of end stage renal disease and blindness in the working population, more than ever is there a demand to develop clinical interventions which can both delay and prevent disease progression. Connexins are membrane bound proteins that can form pores (hemichannels) in the cell membrane. Gated by cellular stress and injury, they open under pathophysiological conditions and in doing so release ‘danger signals’ including adenosine triphosphate into the extracellular environment. Linked to sterile inflammation via activation of the nod-like receptor protein 3 inflammasome, targeting aberrant hemichannel activity and the release of these danger signals has met with favourable outcomes in multiple models of disease, including secondary complications of diabetes. In this review, we provide a comprehensive update on those studies which document a role for aberrant connexin hemichannel activity in the pathogenesis of both diabetic eye and kidney disease, ahead of evaluating the efficacy of blocking connexin-43 specific hemichannels in these target tissues on tissue health and function. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|